David Alan Campbell, President and CEO at Janux Therapeutics, Inc. (JANX), sold 50,000 shares at $53.22 ($2.7M) on 2024-10-28, disclosed to the SEC on 2024-10-30.
Scheduled sale ($2.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.22 | 13,897 | $740K | 27.6% |
| 2 | $53.22 | 13,897 | $740K | 27.6% |
| 3 | $53.94 | 11,103 | $599K | 22.4% |
| 4 | $53.94 | 11,103 | $599K | 22.4% |
| Total | $53.54 avg | 50,000 | $2.7M | 100% |
| Filing → |
| JANX | SELL | 2024-12-27 | $1.4M | — | Filing → |
| JANX | SELL | 2024-12-03 | $1.0M | — | Filing → |
| JANX | SELL | 2024-11-27 | $2.6M | — | Filing → |